Tau Peptide (45-73) ESPLQTPTEDGSEEPGSETSDAKSTPTAE-acid

  • Description

  • Application Data

Description

Phosphoprotein involved in microtubule assembly and stability as well as brain development

See full description

Application Data

Catalogue number crb1000520
Molecular Weight 2976.3
Sequence (one letter code) ESPLQTPTEDGSEEPGSETSDAKSTPTAE-acid
Sequence (three letter code) H-Glu-Ser-Pro-Leu-Gln-Thr-Pro-Thr-Glu-Asp-Gly-Ser-Glu-Glu-Pro-Gly-Ser-Glu-Thr-Ser-Asp-Ala-Lys-Ser-Thr-Pro-Thr-Ala-Glu-OH
Purity >95%
Storage -20°C
References

Šimić et al (2016) Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules 6(1) 6 PMID: 26751493

Gendreau and Hall (2013) Tangles, Toxicity, and Tau Secretion in AD – New Approaches to a Vexing Problem. Front. Neurol. 4 PMID: 24151487

Manufactured in: United Kingdom
Data Sheet Material Safety Data Sheet (MSDS)

Amino acids 45-73, derived from the exon 2/insert 1 domain, of tubulin-associated unit (tau). Tau is a phosphoprotein protein involved in microtubule (MT) assembly and stability as well as brain development. Tau is phosphorylated at multiple sites by several protein kinases, including cyclic-AMP-dependent protein kinases and casein kinase type-1. Tau phosphorylation causes tau to change shape negatively regulating its ability to stimulate MT assembly. Tau is also glycosylated, and O-glycosylation may have a role in its subcellular localisation and degradation.

Malfunctioning tau protein contributes to the structural core of the paired helical filaments (PHFs), which make up neurofibrillary tangles (NFTs). NFTs are often observed in neurodegenerative disorders, such as Alzheimer’s disease and other tauopathies. Tau is expressed from a single gene and is alternatively spliced to yield six different isoforms in the adult central nervous system (CNS)

Tau Peptide (45-73)

Cat No.Pack SizePriceQty.
0.5mg£85.00
1mg£110.00
Bulk Quote